I think NP needs to be judged for the risks and de

I think NP needs to be judged for the risks and decisions he has made over the years as a CEO , not whether he and Dr Bruce had a split and speculation on why. That’s national enquirer type stuff. Fact of the matter is, Dr P is an advocate of Leronlimab and has said that pretty much in every interview he has had since he no longer has a contract with Cytodyn. And many of us know the risks NP has taken to get Cytodyn where it is today. It used to be in bad shape and recently was selling for under a buck a share. This company now has a market cap of 2.5 billion dollars. That takes a skilled individual to do this . As a retired executive I know what this guy has been through, especially in the past 6 months battling to get this drug recognized for what it is but also for putting the right agreements in place for manufacturing , and now leveraging global opportunities for EUA and by doing so, challenging the FDA to reject the EUA. The guy is savvy...